Herpes type 2, also called HSV-2, is a sexually transmitted virus that causes genital herpes. Around 520 million people between ages 15 and 49 are living with genital HSV-2 worldwide, making it one of the most common infections on the planet. More than 1 in 5 adults globally has a genital herpes infection when both HSV-1 and HSV-2 genital cases are counted together. Despite how widespread it is, many people with HSV-2 never realize they carry it.
How HSV-2 Differs From HSV-1
HSV-1 and HSV-2 are closely related viruses that share about 50% of their genetic code. Both are double-stranded DNA viruses that belong to the same family, and both can cause sores on the mouth or genitals. The key difference is location preference: HSV-1 typically causes oral herpes (cold sores), while HSV-2 almost always infects the genital area. HSV-2 also tends to reactivate more frequently when it infects the genitals compared to HSV-1 in the same location.
Both viruses share a defining trait: once you’re infected, the virus travels to nerve cells near the spine and stays there permanently. It can remain dormant for weeks, months, or years, then reactivate and travel back to the skin’s surface. This ability to hide in the nervous system is why herpes is a lifelong infection, though outbreaks typically become less frequent over time.
How HSV-2 Spreads
HSV-2 transmits through direct skin-to-skin contact during sex, including vaginal, anal, and oral contact. What makes the virus particularly efficient at spreading is that it doesn’t require a visible outbreak to pass between partners. In fact, about 70% of HSV-2 transmissions happen during periods when the infected person has no symptoms at all. This is called asymptomatic viral shedding, where the virus is active on the skin surface without causing noticeable sores.
HSV-2 sheds asymptomatically more often than HSV-1 does in the genital area. This means someone with genital HSV-2 can periodically pass the virus to a partner even during stretches when they feel completely fine and have no visible signs of infection. Condoms reduce the risk but don’t eliminate it, since the virus can be present on skin not covered by a condom. In one study, people who used condoms more than 75% of the time acquired HSV-2 at roughly half the rate of those who never used condoms (4.6% versus 8%).
What Symptoms Look Like
Many people with HSV-2 have mild symptoms or none at all, which is a major reason the virus spreads so easily. When symptoms do appear, the first outbreak is usually the worst. A primary infection can cause painful genital ulcerations that last 7 to 10 days or longer if healing is slow. Some people also experience flu-like symptoms, swollen lymph nodes, or neurological discomfort during a first episode.
The classic pattern starts with a prodrome, a warning phase of burning or tingling at the site where sores are about to appear. Small fluid-filled blisters then form, break open into shallow ulcers, and eventually crust over and heal. But this textbook presentation is absent in many infected people. Some experience only mild irritation, small cracks in the skin, or symptoms so subtle they’re mistaken for a yeast infection, ingrown hair, or general irritation.
Recurrent outbreaks are shorter and less severe than the first one. They tend to happen most frequently in the first year after infection, then taper off. Some people have several outbreaks a year, others have one or two, and some go years between episodes.
How HSV-2 Is Diagnosed
There are two main ways to test for HSV-2: a swab test and a blood test. If you have an active sore, a healthcare provider can swab the lesion and test for the virus directly. This is the most reliable method during an outbreak.
Blood tests look for antibodies your immune system produces in response to the virus. The catch is timing: after exposure, it can take up to 16 weeks for antibodies to reach detectable levels. Testing too early can produce a false negative. Blood tests for herpes also carry a higher chance of false positives compared to STI tests for infections like chlamydia or gonorrhea, so a positive result sometimes requires a follow-up confirmatory test.
Treatment and Daily Management
There is no cure for HSV-2, but antiviral medications effectively reduce symptom severity, shorten outbreaks, and lower the risk of passing the virus to a partner. Treatment falls into two approaches.
Episodic treatment means taking antiviral medication at the first sign of an outbreak. Starting within the first day of symptoms, or ideally during the prodrome phase before sores appear, gives the best results. A typical course lasts a few days and can significantly shorten how long an outbreak lasts.
Suppressive therapy involves taking antiviral medication daily, regardless of whether you’re having symptoms. This approach is common for people who experience frequent outbreaks (roughly six or more per year) or who want to reduce the chance of transmitting the virus to a sexual partner. Daily suppressive therapy cuts both outbreak frequency and the rate of asymptomatic shedding.
Risks During Pregnancy
HSV-2 carries specific risks for pregnant women, particularly regarding transmission to the baby during delivery. The level of risk depends almost entirely on when the mother acquired the infection.
A mother who contracts HSV-2 for the first time near the end of pregnancy poses the greatest danger to the newborn, with transmission rates as high as 60%. This is because her immune system hasn’t had time to build antibodies that would cross the placenta and protect the baby. A mother with a recurrent infection, someone who’s had HSV-2 for months or years, has a transmission risk below 2% during delivery because she has protective antibodies that pass to the infant.
Neonatal herpes is rare but serious. For women with a known history of genital herpes, healthcare providers typically check for active lesions near the due date and may recommend antiviral medication in the final weeks of pregnancy to prevent an outbreak at delivery.
Living With HSV-2
An HSV-2 diagnosis often hits harder emotionally than physically. For many people, outbreaks are infrequent and mild, and daily life is largely unaffected. The social stigma around herpes tends to be far more burdensome than the virus itself, especially given how common the infection actually is.
Practical steps that reduce outbreak frequency include managing stress, getting adequate sleep, and taking suppressive antiviral medication if outbreaks are frequent. For sexual relationships, consistent condom use combined with suppressive therapy significantly lowers transmission risk. Open communication with partners, while uncomfortable, is both an ethical responsibility and often less dramatic in practice than people fear. Many couples where one partner has HSV-2 and the other doesn’t successfully manage the risk over years without transmission.